Lanxess AG · XETR:LXS

Lanxess — FY2008 Earnings Presentation

56 slides from Lanxess's earnings presentation, March 2009

  1. Slide 1: LANXESS – FY 2008 Roadshow

    LANXESS – FY 2008 Roadshow Successful 2008 Dr. Axel C. Heitmann, CEO Matthias Zachert, CFO March 2009 FY 2008 Results Roadshow Presentation Chart-No. 1

  2. Slide 2: Safe harbour statement

    Safe harbour statement This presentation contains certain forward-looking statements, including assumptions, opinions and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, devel

  3. Slide 3: Agenda

    Agenda ƒ Executive summary ƒ Financial review FY 2008 ƒ Outlook and measures adopted to address the crisis March 2009 FY 2008 Results Roadshow Presentation Chart-No. 3

  4. Slide 4: 2008 – a healthy and profitable year for LANXESS

    2008 – a healthy and profitable year for LANXESS Sales [€ million] EBITDA* [€ million] Net income [€ million] 6,608 6,576 + 53% 719 721 171 112 2007 2008 2007 2008 2007 2008 EBITDA* margin 10.9% 11.0% * pre exceptionals March 2009 FY 2008 Results Roadshow Presentation Chart-No. 4

  5. Slide 5: Sustainable investment for future success

    Sustainable investment for future success Sales BRIC countries [€ million] Capital expenditures* [€ million] R&D expenditures [€ million] + 41% + 25% + 10% 1,061 751 356 284 88 97 2007 2008 2007 2008 2007 2008 Share of sales R&D rate** 11.4% 16.1% 1.3% 1.5% * intangible assets and property, plant an

  6. Slide 6: LANXESS levels with peer group

    LANXESS levels with peer group EBITDA* 2007 EBITDA* 2008 18.2% 16.0% 14.2% 14.6% 13.9% 11.1% 13.6% 11.0% 10.9% 10.7% 9.5% 9.7% 9.5% 8.8% 9.1% 6.3% Ø 12.4% Ø 11.0% * pre exceptionals; source: annual reports 2007 and 2008, LANXESS estimates March 2009 FY 2008 Results Roadshow Presentation Chart-No. 6

  7. Slide 7: Proportion of profitable businesses rose for 4th straight year

    Proportion of profitable businesses rose for 4th straight year Profitability distribution (share of sales) EBITDA* margin ~75% ~85% ~60% Nearly tripled ~45% > 10% ~30% ~20% ~20% ~15% Reduced 5 - 10% ~30% ~30% ~5% ~20% Eliminated < 5% ~25% ~40% 2004 2005 2006 2007** 2008 * pre exceptionals; ** except

  8. Slide 8: Targets set for 2008 achieved despite difficult Q4

    Targets set for 2008 achieved despite difficult Q4 9 EBITDA* between € 710 - 730 million 9 EBITDA* margin: Peer group profitability 9 No business with < 5% EBITDA* margin Investment grade rating * pre exceptionals 9 March 2009 FY 2008 Results Roadshow Presentation Chart-No. 8

  9. Slide 9: Earnings increased four years in a row – despite difficult Q4 2008

    Earnings increased four years in a row – despite difficult Q4 2008 EBITDA* [€ million] 719 721 675 581 -24% Q4 447 Q3 Q2 Q1 2004 2005 2006 2007 2008 6.6% 8.1% 9.7% 10.9% 11.0% EBITDA* margin * pre exceptionals March 2009 FY 2008 Results Roadshow Presentation Chart-No. 9

  10. Slide 10: Sales growth especially in Performance Polymers

    Sales growth especially in Performance Polymers Performance Polymers Advanced Intermediates Performance Chemicals Sales [€ million] Sales [€ million] Sales [€ million] 3,280 2,680 + 22% 1,970 1,930 1,204 1,310 - 2% + 9% 2007 2008 2007 2008 2007 2008 March 2009 FY 2008 Results Roadshow Presentation C

  11. Slide 11: Dividend adjustment

    Dividend adjustment Dividend per share [€] ƒ Proposed dividend: € 0.50 per share ƒ Total payout € ~41.6 million 1.00 ƒ Allowance made for uncertainties in global economy and main customer markets as well as business decline in Q4 0.50* 0.25 0 2005 2006 2007 2008 * planned March 2009 FY 2008 Results

  12. Slide 12: Operational growth in Asia and EMEA somewhat mitigated by decline in Germany

    Operational growth in Asia and EMEA somewhat mitigated by decline in Germany Sales by Region (in %) Regional development of sales (€ m) 6,608 6,576 Operational development* Asia Germany 1,214 1,156 -4.8% 18 22 Asia + 19% 1,584 1,798 Americas + 5% +13.5% 2,196 EMEA 2,201 + 10% (excl. Germany) +0.2% E

  13. Slide 13: Solid operational performance offset sharp rise in input costs

    Solid operational performance offset sharp rise in input costs FY Sales variances Price Volume Currency Portfolio Sales Performance Polymers +14% -5% -4% +17% ƒ Price increases in all segments Advanced Intermediates +5% +6% -2% 0% ƒ Operational growth of 6% achieved Performance Chemicals +7% -6% -3%

  14. Slide 14: Agenda

    Agenda ƒ Executive summary ƒ Financial review FY 2008 ƒ Outlook and measures adopted to address the crisis March 2009 FY 2008 Results Roadshow Presentation Chart-No. 14

  15. Slide 15: FY 2008 financial overview: operationally successful

    FY 2008 financial overview: operationally successful (€ m) FY 2007 FY 2008 Δ in % Sales 6,608 6,576 -0.5% ƒ Sales on stable level as healthy pricing compensated lower EBITDA pre except. 719 721 0.3% volumes, currency and portfolio margin 10.9% 11.0% effect ƒ Despite soaring raw material Net Income 1

  16. Slide 16: Strong P&L reflects well managed business in a tougher environment

    Strong P&L reflects well managed business in a tougher environment (€ m) FY 2007 FY 2008 Δ in % Sales 6,608 6,576 -0% ƒ Necessary price increases (+9%) on par with unfavorable portfolio Cost of sales -5,147 -5,116 -1% (-4%) and volume (-3%) as well as SG&A -915 -928 1% currency effects (-3%) R&D -88

  17. Slide 17: FY 2008 successfully performed and delivered

    FY 2008 successfully performed and delivered FY 2007 FY 2008 Sales ƒ Sales increased in Performance Polymers and Advanced (€ m) 3,280 Intermediates as increased 3,500 3,000 2,680 prices outweigh lower volumes. 2,500 1,970 1,930 2,000 Performance Chemicals sales 1,500 1,204 1,310 are slightly reduced

  18. Slide 18: Performance Polymers: a solid business in challenging times

    Performance Polymers: a solid business in challenging times (€ m) FY 2007 FY 2008 ƒ Sales increased on the back of healthy pricing in all BUs and a solid contribution of Petroflex, offsetting Sales 2,680 3,280 unfavorable currencies and lower volumes ƒ Stronger pricing offsets lower volumes in almos

  19. Slide 19: Advanced Intermediates: sales and EBITDA increase demonstrate resilience of business

    Advanced Intermediates: sales and EBITDA increase demonstrate resilience of business (€ m) FY 2007 FY 2008 ƒ Nice volumes and good pricing in both BUs overcompensated adverse currency effects Sales 1,204 1,310 ƒ Healthy demand in crop protection and good volumes from Asia as well as price-pass-throu

  20. Slide 20: Performance Chemicals: Q4 burdened FY result

    Performance Chemicals: Q4 burdened FY result (€ m) FY 2007 FY 2008 ƒ Slight decrease in sales as good pricing mitigated negative volume and currency effects Sales 1,970 1,930 ƒ Improved pricing in all BUs but MPP EBIT 183 129 ƒ Decreased volumes in almost all BUs Depr. / Amort. 88 82 ƒ End market de

  21. Slide 21: Balance Sheet: only slight increase in net working capital, net debt rises due to acquisition

    Balance Sheet: only slight increase in net working capital, net debt rises due to acquisition (€ m) Dec 31, 2007 Sep 30, 2008 Dec 31,2008 Dec 31, 2007 Sep 30, 2008 Dec 31,2008 Non-current Assets 1,806 2,150 2,228 Stockholders’ Equity 1,525 1,645 1,407 Intangible assets 33 130 145 thereof minority in

  22. Slide 22: Special focus on working capital management

    Special focus on working capital management % of sales**: 21.7% 20.1% 20.2% 20.3% 19.6% ƒ Inventory: Sequential decrease in Total WC* €1,468 €1,439 €1,369 €1,217 €1,289 Q4 due to lower raw material prices, in € m: destocking and de-valuation 2500 2000 1137 1065 1500 924 725 ƒ Receivables: Very tight

  23. Slide 23: Solid financing in place

    Solid financing in place Liquidity and maturity profile until 2014 In € m Bond** 500 400 Term Loan** 300 Short-term 200 Facilities** Drawn 100 0 Cash Synd. -100 Credit Un-drawn* -200 Facility -300 € 1.4 bn -400 -500 2009 2010 2011 2012 2013 2014 LANXESS has financial liquidity headroom of ~1.7 bn *

  24. Slide 24: Cash flow indicates persisting operational stability

    Cash flow indicates persisting operational stability (€ m) FY 2007 FY 2008 ƒ 2007 profit before Tax burdened by Profit before Tax 172 229 expenses in connection with the divestment of BU LUP Depreciation & amortization 298 279 ƒ Operating cash flow for 2008 Gain from sale of assets -3 -15 contains ~

  25. Slide 25: Agenda

    Agenda ƒ Executive summary ƒ Financial review FY 2008 ƒ Outlook and measures adopted to address the crisis March 2009 FY 2008 Results Roadshow Presentation Chart-No. 25

  26. Slide 26: Substantial further decline of raw material prices in Q1 2009 likely to trigger additional inventory adjustments

    Substantial further decline of raw material prices in Q1 2009 likely to trigger additional inventory adjustments Global raw materials index* [%] ƒ Inventory devaluation in Q4 2008 according to year end prices amounted to ~35 million EUR 200 ƒ Further decline in prices likely 180 leads to additional

  27. Slide 27: 2009: no improvement in Q1

    2009: no improvement in Q1 Current business situation ƒ Business trend remains extremely weak - Especially hard hit: Performance Polymers - Less hit: Advanced Intermediates Q1 2009 ƒ Operationally: Q1 2009 not above Q4 2008 ƒ Inventory write-downs due to drop in raw material prices ƒ Cost reduction

  28. Slide 28: LANXESS focus on “self-help” measures

    LANXESS focus on “self-help” measures Visibility of demand development remains low Governmental demand stimuli Gradual consumer spending recovery End of customer destocking ? ƒ Timing ƒ Magnitude of impact Substantial LANXESS “self-help” measures coming into effect LANXESS “Challenge09” Lower raw ma

  29. Slide 29: Flexible asset management on all levels

    Flexible asset management on all levels Plant level Site level Global level Challenge of substantial lower and volatile load level of chemical plants ƒ Plant – Site – World net ƒ Chemical batch versus continuous reactions ƒ Co-products ƒ Material flow and energy network Tailor-made solutions for dif

  30. Slide 30: Challenge09: specific measures in response to the crisis

    Challenge09: specific measures in response to the crisis Flexible asset management (plant, site and global) 1 Adherence to price-before-volume strategy Savings volume: € 250 million in 2 years Temporary targeted cost reductions in specific areas 2 based on ƒ reduction of energy, infrastructure servi

  31. Slide 31: Global personnel measures implemented

    Global personnel measures implemented Performance Polymers Advanced Intermediates Performance Chemicals Group Level HR measures Tariff employees in Germany ƒ 35-hour week introduced in March 2009 with corresponding pay reduction ƒ No variable compensation components for 2009 Managerial staff ƒ Compe

  32. Slide 32: Challenge09: substantial savings effective already 2009

    Challenge09: substantial savings effective already 2009 In € m 2008 2009 2010 Σ 2009 2010 Break down of cost savings 2009 ƒ Reduction of remuneration ~€65 m Cost savings ƒ Reduction of G&A costs ~€20 m mitigating volume decline 45 130 120 250 ƒ Additional projects ~€45 m - Restructuring BUs BTR, TRP

  33. Slide 33: Cash discipline to address weak business environment

    Cash discipline to address weak business environment In € m 2009 2010 Reduction in planned cash outs ~280 ~30 Thereof Capex ~100 Cash protection measures 2009 include ƒ Delay of investments such as for BTR, SCP and headquarters move ƒ Cost savings measures ƒ Reduced spending for maintenance ƒ HR rem

  34. Slide 34: LANXESS achieved its targets in a challenging macroeconomic environment

    LANXESS achieved its targets in a challenging macroeconomic environment 9 EBITDA* targeted between €710 m and €730 m 9 EBITDA* margin: Peer group profitability 9 No business < 5% EBITDA* margin Investment grade rating * EBITDA figures pre exceptionals 9 March 2009 FY 2008 Results Roadshow Presentati

  35. Slide 35: March 2009 FY 2008 Results Roadshow Presentation Chart-No. 35

    March 2009 FY 2008 Results Roadshow Presentation Chart-No. 35

  36. Slide 36: Appendix

    Appendix March 2009 FY 2008 Results Roadshow Presentation Chart-No. 36

  37. Slide 37: Portfolio management allows for regrouping of LANXESS businesses along chemical segmentation

    Portfolio management allows for regrouping of LANXESS businesses along chemical segmentation Performance Polymers Performance Polymers Advanced Intermediates Performance Chemicals Butyl Rubber Basic Chemicals Material Protection Products Polybutadiene Rubber Saltigo Inorganic Pigments Technical Rubb

  38. Slide 38: Serving global markets with world-wide rubber manufacturing network

    Serving global markets with world-wide rubber manufacturing network Butyl Rubber ƒ Zwijndrecht, Belgium ƒ Sarnia, Canada ƒ Singapore (planned) Performance Butadiene Rubbers ƒ Port Jerome, France ƒ Dormagen, Germany ƒ Orange TX, USA Technical Rubber Products ƒ La Wantzenau, France Cabo, Brazil ƒ Dorm

  39. Slide 39: Asian growth dynamics are a major driver for LANXESS

    Asian growth dynamics are a major driver for LANXESS Example: Asian rubber demand BTR PBR TRP Americas Asia-Pacific Americas Asia-Pacific Americas Asia-Pacific 25% 51% 27% 45% 29% 40% EMEA EMEA EMEA 24% 28% 31% End Uses ƒ 86% automotive/ tyres ƒ 69% automotive/ tyres ƒ 46% automotive ƒ 14% various o

  40. Slide 40: LANXESS has a broad customer portfolio with varying demand patterns

    LANXESS has a broad customer portfolio with varying demand patterns LANXESS sales distribution by industry, 2008 Others Agro Tyre Construction Consumer Automotive Goods Chemicals March 2009 FY 2008 Results Roadshow Presentation Chart-No. 40

  41. Slide 41: Financing and liquidity situation is comfortable

    Financing and liquidity situation is comfortable ƒ Volume : €500 m ƒ Maturity : June 2012 Eurobond ƒ Covenant : No financial covenant; Change of Control clause ƒ Coupon : 4.125% ƒ Volume : €1.4 bn, undrawn Revolving ƒ Maturity : November 2014 credit ƒ Covenant : Net financial debt* / EBITDApre < 3.5

  42. Slide 42: Change of pension accounting of Defined Benefit Plans as of 2009

    Change of pension accounting of Defined Benefit Plans as of 2009 (switch from Corridor to SoRIE method) Corridor method SoRIE ƒ The portion of unrecognized gains and losses ƒ SoRIE = Statement of Recognized Income & which exceeds 10% of the higher amount of Expense DBO or plan assets is amortized th

  43. Slide 43: Pension underfunding – minor issue for LANXESS

    Pension underfunding – minor issue for LANXESS Clear improvement of funded status ƒ Significant improvements of funded status by ~ € 300 m since 2005 to only € 381 m Defined - benefit obligation (funding ratio of ~ 65% achieved) External plan assets Underfunding - Start up of CTA in 2007 (in € m) -

  44. Slide 44: Q4 2008 operational performance impacted by sharp rise in input costs and lower demand

    Q4 2008 operational performance impacted by sharp rise in input costs and lower demand Sales variances (€ m) Price Volume Currency Portfolio Sales Performance Polymers +13% -32% +6% +21% ƒ Price increases in all segments Advanced Intermediates +6% -6% +3% 0% ƒ Drastic volume decline effect on Perfor

  45. Slide 45: Q4 2008 financial overview: burdened by low demand and higher input costs

    Q4 2008 financial overview: burdened by low demand and higher input costs (€ m) Q4 2007 Q4 2008 Δ in % Sales 1,465 1,462 -0.2% ƒ Sales remain almost unchanged as good pricing, portfolio and EBITDA pre except. 114 87 -23.7% favorable currency effects offset margin 7.8% 6.0% drastic decline in volumes

  46. Slide 46: P&L tightly managed in challenging times

    P&L tightly managed in challenging times (€ m) Q4 2007 Q4 2008 Δ in % Sales 1,465 1,462 0% ƒ Q4 burdened by Cost of sales -1,165 -1,205 3% ƒ still high raw material costs due to contract prices being SG&A -222 -224 1% above spot market R&D -20 -22 10% ƒ Underutilization due to Other op. income / exp

  47. Slide 47: Sustainable improvement trend of financials, based on strong operations

    Sustainable improvement trend of financials, based on strong operations In € m 2004 2005 2006 2007 2008 EBITDA* 447 581 675 719 721 EBITDA* margin 6.6% 8.1% 9.7% 10.9% 11% Strength Net financial debt 1,135 680 511 460 864 Net fin. debt / EBITDA* 2.5x 1.2x 0.8x 0.6x 1.2x Underlying EPS** 0.65 1.19 2.

  48. Slide 48: The economic environment deteriorated in Q4

    The economic environment deteriorated in Q4 EBITDA pre exceptionals [€m] +4.8% -23.7% ƒ 9M 2008 performance was still 650 120 supported by relatively solid 600 634 100 economic environment 605 80 114 550 60 87 500 ƒ In Q4 2009, volume decline 40 weighed heavily on EBITDA 450 20 400 0 9M 9M Q4 Q4 ƒ I

  49. Slide 49: Advanced Intermediates very strong while other segments were impacted

    Advanced Intermediates very strong while other segments were impacted Q4 2007 ƒ Sales in Performance Polymers and Q4 2008 Sales Advanced Intermediates increase due to (€ m) 741 higher prices while Performance Chemicals 800 684 remains below last year’s level due to 600 456 392 substantial exposure t

  50. Slide 50: Performance Polymers: tough quarter driven by volume decline accelerated by customer destocking

    Performance Polymers: tough quarter driven by volume decline accelerated by customer destocking (€ m) Q4 2007 Q4 2008 ƒ Sales increased as healthy pricing, supportive currency effects in all BUs, as well as portfolio (Petroflex), offset Sales volume decrease 684 741 ƒ All BUs managed to increase pri

  51. Slide 51: Advanced Intermediates: strongly benefiting from agro and pharma end markets

    Advanced Intermediates: strongly benefiting from agro and pharma end markets (€ m) Q4 2007 Q4 2008 ƒ Slight increase in topline on the back of healthy pricing and currencies, successfully offsetting lower volumes Sales 308 317 ƒ Softer volumes in BAC are mitigated by stronger volumes in SGO EBIT 16

  52. Slide 52: Performance Chemicals: customer industry shutdowns trigger weak Q4

    Performance Chemicals: customer industry shutdowns trigger weak Q4 (€ m) Q4 2007 Q4 2008 ƒ Price increases and favorable currencies only mitigate volume collapse Sales 456 392 ƒ All BUs with price increases and volume declines, except MPP on stable level EBIT 14 -33 ƒ IPG with still relatively solid

  53. Slide 53: Exceptional items incurred in Q4 2007 and Q4 2008

    Exceptional items incurred in Q4 2007 and Q4 2008 (€ m) Q4 2007 Q4 2008 Exceptional thereof D&A Exceptional thereof D&A Performance Polymers 0 0 18 5 ƒ Restructuring BTR and TRP (NBR) ƒ Exceptionals for integration Advanced Intermediates 0 0 0 0 Petroflex Performance Chemicals 12 2 31 7 ƒ Restructur

  54. Slide 54: Exceptional items incurred in FY 2007 and FY 2008

    Exceptional items incurred in FY 2007 and FY 2008 (€ m) FY 2007 FY 2008 Exceptional thereof D&A Exceptional thereof D&A Performance Polymers 0 0 77 11 ƒ Restructuring BTR and TRP (NBR) ƒ Exceptionals for integration Advanced Intermediates 0 0 0 0 Petroflex Performance Chemicals 16 2 38 8 ƒ Restructu

  55. Slide 55: Abbreviations

    Abbreviations Performance Polymers Advanced Intermediates BTR Butyl Rubber BAC Basic Chemicals PBR Performance Butadiene Rubbers SGO Saltigo TRP Technical Rubber Products SCP Semi-Crystalline Products Performance Chemicals MPP Material Protection Products IPG Inorganic Pigments FCC Functional Chemic

  56. Slide 56: Contact detail Investor Relations

    Contact detail Investor Relations Oliver Stratmann Verena Simiot Head of Investor Relations Assistant Investor Relations Tel. : +49-214 30 49611 Tel. : +49-214 30 23851 Fax. : +49-214 30 959 49611 Fax. : +49-214 30 40944 Mobile : +49-175 30 49611 Mobile : +49-175 30 23851 Email : Oliver.Stratmann@la

Lanxess — FY2008 Earnings Presentation on 6ix